Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Gross Profit (2024 - 2025)

Silence Therapeutics' Gross Profit history spans 2 years, with the latest figure at $22000.0 for Q4 2025.

  • For Q4 2025, Gross Profit fell 99.91% year-over-year to $22000.0; the TTM value through Dec 2025 reached $344000.0, down 98.91%, while the annual FY2025 figure was $344000.0, 98.91% down from the prior year.
  • Gross Profit for Q4 2025 was $22000.0 at Silence Therapeutics, down from $95000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $23.3 million in Q4 2024 and bottomed at -$2.6 million in Q2 2024.